Results 101 to 110 of about 3,440,112 (288)

Cardiovascular-kidney-metabolic syndrome (literature review)

Inter Collegas
Background. In recent years, the importance of the concept of cardiovascular-kidney-metabolic health has been increasingly emphasized, reflecting the close pathogenetic and clinical relationship between cardiovascular disease, renal dysfunction, and metabolic health in general.
T.V. Ashcheulova, N.M. Herasymchuk, T.M. Ambrosova, O.A. Kochubiei, U.S. Herasymchuk   +4 more
openaire   +1 more source

Differential Association of Regional Adipose Tissue Deposit with Cardiovascular-Kidney-Metabolic Syndrome [PDF]

Introduction: Cardiovascular-kidney-metabolic (CKM) syndrome is a condition characterized by the interplay between cardiovascular disease, kidney disease, diabetes, and obesity, resulting in adverse health outcomes.
Sang-Eun Lee, Wook Bum Pyun, In-Jeong Cho   +2 more
core   +1 more source

Lithium‐related adverse drug reactions in children: A case–control study comparing lithium to second‐generation antipsychotics in VigiBase

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to improve the understanding of lithium's safety profile by analysing the frequency and distribution of reported adverse drug reactions (ADRs) compared to second‐generation antipsychotics (SGAs). Methods Individual case safety reports from VigiBase (1968–October 2023) involving individuals older than 2 years, with lithium or SGAs ...
Lisa T. Ringeling, Ravish N. Gangapersad, Lillian Lieuw, Patrick C. Souverein, Eibert R. Heerdink, Pilar Garcia‐Gomez, Manon H. J. Hillegers, Birgit C. P. Koch, Bram Dierckx   +8 more
wiley   +1 more source

Translating localized renal reprogramming to systemic protection: A comprehensive review of SGLT2 inhibitors in cardiovascular-kidney-metabolic syndrome

Precision Medication
Cardiovascular-kidney-metabolic syndrome is a multifaceted condition encompassing chronic kidney disease, end-stage renal disease, and cardiovascular diseases stemming from underlying cardiometabolic disorders. Sodium-glucose co-transporter 2 inhibitors,
Durlav Chowdhury, Priyanka Dubey, Rahul Manna, Sarvesh K. Paliwal, Surendra H. Bodakhe   +4 more
doaj   +1 more source

Extracellular Vesicles‐Based Biological Macromolecule Delivery Systems: Biogenesis, Characterization, and Emerging Clinical Applications

Biotechnology and Bioengineering, EarlyView.
ABSTRACT Extracellular vesicles (EVs) are nanoscale membrane‐bound structures that play a pivotal role in intercellular communication by transporting bioactive molecules, including proteins, lipids, nucleic acids, and organelles, between cells. Originating from the endosomal pathway, EVs reflect the physiological and pathological status of their parent
Emine İncilay Torunoğlu, Zeynep Betül Sarı, Muhammed Emin Sarı, Erdi Can Aytar   +3 more
wiley   +1 more source

Pathophysiology and emerging biomarkers of cardiovascular-renal-hepato-metabolic syndrome

Frontiers in Cardiovascular Medicine
Cardiovascular-Renal-Hepatic-Metabolic (CRHM) syndrome characterizes a complex, interrelated disease framework that encompasses cardiovascular disease, chronic kidney disease (CKD), metabolic dysfunction-associated steatotic liver disease, and metabolic ...
John Nzobokela, Lweendo Muchaili, Lweendo Muchaili, Alick Mwambungu, Sepiso K. Masenga, Sepiso K. Masenga, Sepiso K. Masenga, Sepiso K. Masenga, Annet Kirabo, Annet Kirabo, Annet Kirabo, Annet Kirabo, Annet Kirabo   +12 more
doaj   +1 more source

Neighborhood Walkability and Cardio-Kidney-Metabolic Syndrome: A Narrative Review

Cardio-Kidney-Metabolic (CKM) Syndrome is a complex systemic disorder characterized by interactions between metabolic risk factors such as obesity, Type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), and cardiovascular disease (CVD).
Pedro Rafael Vieira de Oliveira Salerno, Vaibhav Shah, Colin Carpenter, Alena Gonzalez, Mohamed Bassiony, Avery Hum, Zhuo Chen, Ariela Baur, Weichuan Dong, Sadeer Al-Kindi   +9 more
core   +1 more source

Metal nanostructure‐coupled label‐free localized surface plasmon resonance biosensors for rapid and sensitive disease diagnosis

BMEMat, EarlyView.
LSPR biosensing enables rapid, sensitive, and low‐sample‐volume detection of biomarkers, with broad applications in diagnosing cancer, infectious, and chronic diseases. Advances in nanostructure design, micro/nanofabrication, and microfluidic integration have expanded the potential of LSPR sensors in biomedical diagnostics.
Zhaoxin Geng, Yunfei Sha, Jiongyan Yang, Hongru Yang, Xiao Liang   +4 more
wiley   +1 more source

The Metabolic Syndrome and Risk of Chronic Kidney Disease: Pathophysiology and Intervention Strategies

Journal of Nutrition and Metabolism, 2012
Metabolic syndrome is characterized by a clustering of cardiovascular risk factors, including abdominal obesity, elevated blood pressure and glucose concentrations, and dyslipidemia.
Heather A. LaGuardia, L. Lee Hamm, Jing Chen   +2 more
doaj   +1 more source

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

BMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim, Marwa Ahmed El‐Naka, Wedad M. Nageeb, Atta Ullah Khan, Noura M. Seleem, Aliaa Abdelghafar, Doaa Zamel, Yang Liu, Qigai He, Wentao Li   +9 more
wiley   +1 more source